The Asian Oncology Society 1st Virtual International Conference

 

The Asian Oncology Society 1st Virtual International Conference
J

Present & Future of Targeted Therapy for Advanced CRC: IO for dMMR/MSI-H Disease, RAS/BRAF Mutations, AMG510, Encorafenib+Binimetinib+Cetuximab, T-DXd for HER2+ mCRC

By The Asian Oncology Society 1st Virtual International Conference FEATURING Jin Li
By The Asian Oncology Society 1st Virtual International Conference FEATURING Jin Li
211 views
February 18, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

19:38
Exelixis

Hypothetical Patient Case: 1L Advanced Renal Cell Carcinoma and Qual…

Feat. R. Alter, A. Rezazadeh

Featured Video

17:48
Exelixis

Hypothetical Patient Case: 1L Advanced Renal Cell Carcinoma With Mul…

Feat. R. Alter, A. Rezazadeh
Gastrointestinal
18:54

Genomic Era of CRC Surgery: Total Mesorectal Excision, CME & CVL, Ta…

The Asian Oncology Society 1st Virtual International Conference

S. Lee

89 views
50:29

Biomarker Driven and Targeted Therapies in CRC: dMMR/MSI-H, HER2 Ove…

The Asian Oncology Society 1st Virtual International Conference

H. Lenz

360 views
16:45

Systemic Treatment for Advanced HCC: Can Sorafenib Improve PFS/ORR v…

The Asian Oncology Society 1st Virtual International Conference

M. Choi

332 views
14:13

IO in Advanced HCC: Can We Achieve Better ORR With 1L Nivo+Ipi? Does…

The Asian Oncology Society 1st Virtual International Conference

M. Choi

150 views
14:19

NGS for Pancreatobiliary Cancer: Maintenance Olaparib Data in Germli…

The Asian Oncology Society 1st Virtual International Conference

M. Choi

354 views
22:56

Managing Gastric Cancer: Can Genetic Analysis and NGS Help? Should W…

The Asian Oncology Society 1st Virtual International Conference

K. Yoshida

32 views
11:02

Present & Future of Targeted Therapy for Advanced CRC: IO for dMMR/M…

The Asian Oncology Society 1st Virtual International Conference

J. Li

211 views